| Cash Flow | 2026-03-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Stock-based compensation | -158 | 27 | 136 |
| Net loss | NaN | NaN | -7,449 |
| Amortization of right of use assets | -46 | -2 | 59 |
| Default on convertible debt | NaN | 90 | NaN |
| Loss on convertible debt conversions | NaN | 43 | NaN |
| Depreciation | NaN | 9 | 14 |
| Change in fair value of warrant liability | -421 | 817 | -394 |
| Change in fair value of derivative liability | NaN | 343 | NaN |
| Prepaid drug product | NaN | 1,200 | -600 |
| Other current assets | -1,338 | 2,623 | -1,283 |
| Interest payable | NaN | NaN | 51 |
| Amortization of debt issuance costs | -71 | 40 | 40 |
| Accounts payable and accrued expenses | -4,301 | 447 | 4,122 |
| Lease liabilities | 45 | 2 | -58 |
| Net loss | 8,155 | -8,425 | NaN |
| Net cash used in operating activities | 1,558 | 0 | -1,596 |
| Net proceeds from exercise of pre-funded warrants | NaN | 0 | 1 |
| Proceeds from promissory notes | -372 | 0 | 422 |
| Net cash provided by financing activities | -373 | 0 | 423 |
| Net increase (decrease) in cash | 1,185 | 0 | -1,173 |
| Cash and cash equivalents at beginning of period | NaN | 1,173 | NaN |
| Cash, end of period | 12 | 0 | NaN |
BIO-PATH HOLDINGS, INC. (BPTH)
BIO-PATH HOLDINGS, INC. (BPTH)